| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | 31-Mar-08 | | Total Revenue | 992,102 | 1,929,414 | 398,981 | 787,992 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 992,102 | 1,929,414 | 398,981 | 787,992 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (649,360) | 786,264 | 1,077,227 | 351,095 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 26,067 | 20,700 | 24,618 | 3,759,664 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,615,395 | 1,122,450 | (702,864) | (3,322,767) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,615,395 | 1,122,450 | (702,864) | (3,322,767) | | Interest Expense | 112,474 | 137,279 | 343,726 | 377,070 | | Income Before Tax | 1,502,921 | 985,171 | (1,046,590) | (3,699,837) | | Income Tax Expense | 604,907 | 284,523 | (240,111) | (1,293,105) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 898,014 | 700,648 | (806,479) | (2,406,732) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 898,014 | 700,648 | (806,479) | (2,406,732) | | Preferred Stock And Other Adjustments | (3,271) | (3,942) |
-
|
-
| | | Net Income Applicable To Common Shares | $894,743 | $696,706 | ($806,479) | ($2,406,732) |
|
0.10% Nasdaq 
Income Statement
